In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...

New research from King’s College London has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases that affect the central nervous ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

Diagnosed with multiple sclerosis at age 35, the FOX News senior meteorologist thought her life was over. Now, nearly two ...

Sanofi has stopped a phase 2 trial of Denali Therapeutics-partnered oditras | Sanofi has stopped a phase 2 trial of the ...

The 48-year-old former cyclist said he initially went to the hospital last September after feeling some pain in his shoulder.

A recent study showed that both cognitive behavioral therapy (CBT) and the mild stimulant modafinil (Provigil) reduced MS ...

Some cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...